Answers are grounded in this paper and cite their sources.
This RCT demonstrated that FORT, compared to an attention placebo control group, resulted in a greater reduction in FCR posttreatment and at 3 months posttreatment in women with breast and gynecological cancer, indicating its potential as a new treatment strategy. We recommend a booster session to sustain gains. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
No takes yet. Share an insight, caveat, or question.
Maheu et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: